Carolina S. Vieira

Twelve-Month Outcomes of Rotated Copper Intrauterine Devices After Immediate Postpartum Insertion.

Journal: Contraception

Published: March 26, 2026

Clarifying analytic decisions and safety monitoring in the IMPLANET trial.

Journal: American journal of obstetrics and gynecology

Published: November 15, 2025

Real-world validation of a bleeding prediction algorithm in levonorgestrel intrauterine device users using the MyIUS mobile app.

Journal: Contraception

Published: March 31, 2025

Norethisterone for prolonged uterine bleeding associated with etonogestrel implant (IMPLANET): a randomized controlled trial.

Journal: American journal of obstetrics and gynecology

Published: February 19, 2025

Pharmacodynamics and pharmacokinetics of a copper intrauterine contraceptive system releasing ulipristal acetate: A randomized proof-of-concept study.

Journal: Contraception

Published: December 16, 2020

Predictors of severe pain during insertion of the levonorgestrel 52 mg intrauterine system among nulligravid women.

Journal: Contraception

Published: April 06, 2020

Intracervical block for levonorgestrel-releasing intrauterine system placement among nulligravid women: a randomized double-blind controlled trial.

Journal: American journal of obstetrics and gynecology

Published: May 11, 2019

Timing of postpartum etonogestrel-releasing implant insertion and bleeding patterns, weight change, 12-month continuation and satisfaction rates: a randomized controlled trial.

Journal: Contraception

Published: November 21, 2018

Levonorgestrel-Releasing Intrauterine System for Women With Polycystic Ovary Syndrome: Metabolic and Clinical Effects.

Journal: Reproductive sciences (Thousand Oaks, Calif.)

Published: January 07, 2016

Presentation and treatment of uterine leiomyoma in adolescence: a systematic review.

Journal: BMC women's health

Published: August 22, 2014

The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome.

Journal: Contraception

Published: October 18, 2011

Postpartum contraception

Journal: Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia

Published: August 07, 2008

Twelve-Month Outcomes of Rotated Copper Intrauterine Devices After Immediate Postpartum Insertion.

Twelve-Month Outcomes of Rotated Copper Intrauterine Devices After Immediate Postpartum Insertion.

Clarifying analytic decisions and safety monitoring in the IMPLANET trial.

Clarifying analytic decisions and safety monitoring in the IMPLANET trial.

Real-world validation of a bleeding prediction algorithm in levonorgestrel intrauterine device users using the MyIUS mobile app.

Real-world validation of a bleeding prediction algorithm in levonorgestrel intrauterine device users using the MyIUS mobile app.

Norethisterone for prolonged uterine bleeding associated with etonogestrel implant (IMPLANET): a randomized controlled trial.

Norethisterone for prolonged uterine bleeding associated with etonogestrel implant (IMPLANET): a randomized controlled trial.

Pharmacodynamics and pharmacokinetics of a copper intrauterine contraceptive system releasing ulipristal acetate: A randomized proof-of-concept study.

Pharmacodynamics and pharmacokinetics of a copper intrauterine contraceptive system releasing ulipristal acetate: A randomized proof-of-concept study.

Predictors of severe pain during insertion of the levonorgestrel 52 mg intrauterine system among nulligravid women.

Predictors of severe pain during insertion of the levonorgestrel 52 mg intrauterine system among nulligravid women.

Intracervical block for levonorgestrel-releasing intrauterine system placement among nulligravid women: a randomized double-blind controlled trial.

Intracervical block for levonorgestrel-releasing intrauterine system placement among nulligravid women: a randomized double-blind controlled trial.

Timing of postpartum etonogestrel-releasing implant insertion and bleeding patterns, weight change, 12-month continuation and satisfaction rates: a randomized controlled trial.

Timing of postpartum etonogestrel-releasing implant insertion and bleeding patterns, weight change, 12-month continuation and satisfaction rates: a randomized controlled trial.

Levonorgestrel-Releasing Intrauterine System for Women With Polycystic Ovary Syndrome: Metabolic and Clinical Effects.

Levonorgestrel-Releasing Intrauterine System for Women With Polycystic Ovary Syndrome: Metabolic and Clinical Effects.

Presentation and treatment of uterine leiomyoma in adolescence: a systematic review.

Presentation and treatment of uterine leiomyoma in adolescence: a systematic review.

The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome.

The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome.

Postpartum contraception

Postpartum contraception

Predictors of severe pain during insertion of the levonorgestrel 52 mg intrauterine system among nulligravid women.

Predictors of severe pain during insertion of the levonorgestrel 52 mg intrauterine system among nulligravid women.